Can hemorrhoids increase calprotectin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Hemorrhoids Increase Calprotectin Levels?

Hemorrhoids can cause false elevations in fecal calprotectin levels due to local bleeding and inflammation, potentially confounding the interpretation of this biomarker when evaluating for inflammatory bowel disease. 1

Understanding Fecal Calprotectin as a Biomarker

Fecal calprotectin is a validated biomarker for intestinal inflammation that:

  • Serves as a non-invasive surrogate marker primarily used to detect inflammatory bowel disease (IBD) and differentiate it from irritable bowel syndrome (IBS) 2
  • Has high negative predictive value for ruling out IBD in undiagnosed, symptomatic patients 2
  • Correlates well with endoscopic and histological disease activity in IBD 2

Factors That Can Elevate Fecal Calprotectin Besides IBD

Fecal calprotectin can be elevated in various conditions other than IBD, including:

  • Infectious gastroenteritis 2, 3
  • Colorectal neoplasia 4
  • NSAID use within the past 6 weeks 2
  • Hemorrhoids - as specifically noted in clinical guidelines 1

Hemorrhoids and Calprotectin Elevation

When patients present with rectal bleeding, the National Comprehensive Cancer Network (NCCN) guidelines specifically mention that:

  • Hemorrhoids should be considered as a potential cause of gastrointestinal bleeding that can affect calprotectin levels 1
  • Patients presenting with blood in the stool should be evaluated for multiple causes, including hemorrhoids, before attributing elevated calprotectin solely to IBD 1

Clinical Approach to Interpreting Calprotectin in Patients with Hemorrhoids

When interpreting calprotectin results in patients with hemorrhoids:

  • Consider that acute bleeding from hemorrhoids may cause falsely elevated calprotectin levels 1, 3
  • In acute presentations with rectal bleeding, flexible sigmoidoscopy is indicated regardless of calprotectin result to distinguish between hemorrhoids and IBD 3
  • For patients with mild symptoms and elevated calprotectin (>150 μg/g), the American Gastroenterological Association suggests endoscopic assessment rather than empiric IBD treatment 1

Practical Recommendations

For accurate interpretation of calprotectin results when hemorrhoids are suspected:

  • Document the presence of hemorrhoids during clinical examination 1
  • Consider repeat calprotectin testing after hemorrhoidal bleeding has resolved 3
  • Use higher thresholds (between 100-250 μg/g stool) to improve positive predictive value for IBD 2
  • Remember that in patients with moderate to severe symptoms suggestive of IBD flare, fecal calprotectin >150 μg/g reliably suggests moderate to severe endoscopic inflammation 1

Important Caveats

  • Fecal calprotectin has limited specificity for IBD as it can be elevated in multiple conditions including hemorrhoids 4, 2
  • In acute diarrhea, calprotectin is likely to be elevated and will not discriminate between IBD and other causes, making endoscopic evaluation necessary 3
  • For patients with rectal bleeding, calprotectin is not sensitive enough to exclude colorectal cancer, and cancer pathway referral should be strongly considered rather than relying solely on calprotectin 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Calprotectin as a Biomarker for Intestinal Inflammation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Elevated Faecal Calprotectin in Acute Settings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.